Xilio Therapeutics Inc (XLO)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 2.36M | 2.26M |
| Operating Income | -23.17M | -23.53M | -20.12M | -17.36M | -18.13M | -17.49M | -14.7M | -14.76M |
| Pre Tax Income | -22.47M | -22.65M | -19.36M | -16.75M | -17.66M | -17.2M | -13.93M | -14.02M |
| Net Income | -22.47M | -22.65M | -19.36M | -16.75M | -17.66M | -17.2M | -13.93M | -14.02M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -22.47M | -22.65M | -19.36M | -16.75M | -17.66M | -17.2M | -13.93M | -14.02M |
| EBITDA | -22.83M | -23.03M | -19.72M | -16.81M | -17.78M | -17.04M | -14.26M | -14.38M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -19.03M | -54.56M | -75.04M | -89.15M | -79.13M |
| Pre Tax Income | -17.31M | -55.22M | -75.8M | -88.22M | -76.4M |
| Net Income | -17.31M | -55.22M | -75.8M | -88.22M | -76.4M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | -8.424 | -2.771 | -3.217 | -2.774 |
| EBIT | -17.31M | -55.22M | -75.8M | -88.22M | -76.4M |
| EBITDA | -18.79M | -53.5M | -73.55M | -87.45M | -77.33M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
